Cohort 2 (Prevalent GLP-1 RA Users) Cohort 2 members comprised the following categories of patients: prior GLP-1 RA users who switched from other GLP-1 RAs to dulaglutide or semaglutide during the patient selection time window (prior GLP-1 RA user but nave to dulaglutide and/or semaglutide) and prior users of dulaglutide and semaglutide who received dulaglutide or semaglutide during the patient selection window (prior GLP-1 RA user not nave to dulaglutide and/or semaglutide)
Note: Medicare beneficiaries wishing to receive a GLP-1 for weight loss alone without a related risk factor will not be eligible for savings under the GLP-1 bridge
Labs study it for telomerase activation, cellular senescence pathways, and lifespan extension models
In the US, major professional leagues including the NBA and NFL operate under their own anti-doping policies
For patients with hyperthyroidism, it might be necessary to adjust their thyroid medications when starting semaglutide
Injectable delivery characteristics Subcutaneous GHK-Cu injection delivers the peptide directly into tissue, bypassing absorption barriers and providing systemic distribution
